ecteinascidin 743 has been researched along with Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belotti, D; Borsotti, P; Carminati, L; D'Incalci, M; Giavazzi, R; Minoli, L; Pinessi, D; Taraboletti, G | 1 |
| Amodei, S; Antonelli, A; Benassi, B; Biroccio, A; D'Incalci, M; Del Bufalo, D; Elli, R; Gabellini, C; Zupi, G | 1 |
| Faircloth, GT; Fiebig, HH; Giavazzi, R; Hendriks, HR; Jimeno, JM; Langdon, SP | 1 |
3 other study(ies) available for ecteinascidin 743 and Melanoma
| Article | Year |
|---|---|
Antimetastatic and antiangiogenic activity of trabectedin in cutaneous melanoma.
Topics: Angiogenesis Inhibitors; Animals; Cell Line; Cell Line, Tumor; Female; Macrophages; Melanoma; Melanoma, Cutaneous Malignant; Melanoma, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Metastasis; NIH 3T3 Cells; Skin Neoplasms; Tissue Inhibitor of Metalloproteinase-1; Trabectedin; Tumor Microenvironment | 2019 |
Telomere dysfunction increases cisplatin and ecteinascidin-743 sensitivity of melanoma cells.
Topics: Antineoplastic Agents; Cisplatin; Dioxoles; DNA Damage; DNA-Binding Proteins; Drug Screening Assays, Antitumor; G2 Phase; Humans; Isoquinolines; Melanoma; Mitosis; Telomerase; Telomere; Tetrahydroisoquinolines; Trabectedin; Transfection; Tumor Cells, Cultured | 2003 |
High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancer.
Topics: Adult; Animals; Antineoplastic Agents, Alkylating; Carcinoma, Non-Small-Cell Lung; Dioxoles; Female; Humans; Isoquinolines; Lung Neoplasms; Male; Melanoma; Mice; Mice, Nude; Middle Aged; Neoplasm Transplantation; Ovarian Neoplasms; Tetrahydroisoquinolines; Trabectedin | 1999 |